977-P: Trends in First-Line Glucose-Lowering Drug Use in Adults with Type 2 Diabetes in Light of Emerging Evidence for SGLT2i and GLP-1RA

Recent utilization trends and predictors of first-line antidiabetic treatment in patients with type 2 diabetes (T2D) remain unexplored.Using Medicare and a large U.S. health insurance database of commercially-insured patients (Clinformatics), we identified adult patients with T2D who initiated first-line antidiabetic treatment during 2013-2019. Quarterly utilization trends were plotted overall and by cardiovascular disease (CVD). We estimated...